Evaluating Blood-Brain Barrier Permeability, Cytotoxicity, and Activity of Potential Acetylcholinesterase Inhibitors: In Vitro and In Silico Study – PubMed Black Hawk Supplements

BLACK HAWK: High quality shilajit supplement for libido

Published article

Acetylcholinesterase inhibitors (AChEIs) remain the first-line treatment for Alzheimer’s disease. However, these drugs are largely symptomatic and often associated with adverse effects. This study aimed to evaluate novel pharmacophores for their in vitro AChEI activity, blood-brain barrier (BBB) permeability, and cytotoxic potential, hypothesizing that a combination of AChEIs could enhance symptom management while minimizing toxicity. A library of 1453 synthetic pharmacophores was assessed using…
Black Hawk Supplements, best supplements in the UK

Evaluating Blood-Brain Barrier Permeability, Cytotoxicity, and Activity of Potential Acetylcholinesterase Inhibitors: In Vitro and In Silico Study - PubMed

Evaluating Blood-Brain Barrier Permeability, Cytotoxicity, and Activity of Potential Acetylcholinesterase Inhibitors: In Vitro and In Silico Study

L M Maboko et al. Pharmacol Res Perspect. 2024 Dec.

Free article

Abstract

Acetylcholinesterase inhibitors (AChEIs) remain the first-line treatment for Alzheimer’s disease. However, these drugs are largely symptomatic and often associated with adverse effects. This study aimed to evaluate novel pharmacophores for their in vitro AChEI activity, blood-brain barrier (BBB) permeability, and cytotoxic potential, hypothesizing that a combination of AChEIs could enhance symptom management while minimizing toxicity. A library of 1453 synthetic pharmacophores was assessed using in vitro and in silico methods to determine their feasibility as an inhibitor of the AChE enzyme. An in-house miniaturized Ellman’s assay determined acellular AChEI activities, while pharmacokinetic properties were evaluated using the SwissADME web tool. The combinational effects of in silico BBB-permeable pharmacophores and donepezil were examined using a checkerboard AChEI assay. Cytotoxicity of active compounds and their synergistic combinations was assessed in SH-SY5Y neuroblastoma and bEnd.5 cells using the sulforhodamine B assay. Cellular AChEI activity of active in silico BBB-permeable predicted compounds was determined using an SH-SY5Y AChE-based assay. An in vitro BBB model was used to assess the effect of compounds on the integrity of the bEnd.5 monolayer. Out of the screened compounds, 12 demonstrated 60% AChEI activity at 5 μM, with compound A51 showing the lowest IC50 (0.20 μM). Five compounds were identified as BBB-permeable, with the donepezil-C53 combination at ¼IC50 exhibiting the strongest synergy (CI = 0.82). Compounds A136 and C129, either alone or with donepezil, showed cytotoxicity. Notably, compound C53, both alone and in combination with donepezil, demonstrated high AChEI activity and promising BBB permeability, warranting further investigation.

Keywords: acetylcholinesterase inhibition; blood–brain barrier; cytotoxicity; synthetic compounds.

PubMed Disclaimer

References

    1. J. Cummings, G. Lee, A. Ritter, and K. Zhong, “Alzheimer’s disease drug development pipeline: 2018,” Alzheimer’s & Dementia: Translational Research & Clinical Interventions 4 (2018): 195–214, https://doi.org/10.1016/j.trci.2018.03.009.
    1. S. Gauthier, P. Rosa‐Neto, J. A. Morais, and C. Webster, World Alzheimer Report 2021: Journey Through the Diagnosis of Dementia (London, England: Alzheimer’s Disease International, 2021).
    1. E. Bomasang‐Layno and R. Bronsther, “Diagnosis and Treatment of Alzheimer’s Disease: An Update,” Delaware Journal of Public Health 7, no. 4 (2021): 74–85, https://doi.org/10.32481/djph.2021.09.009.
    1. V. Revadigar, R. M. Ghalib, V. Murugaiyah, et al., Enzyme Inhibitors Involved in the Treatment of Alzheimer’s Disease (Sharjah, United Arab Emirates: Bentham Science Publishers, 2014).
    1. K. M. Carvalho, E. Winter, and A. M. de Souza Antunes, “Analysis of Technological Developments in the Treatment of Alzheimer’s Disease Through Patent Documents,” Intelligent Information Management 7, no. 5 (2015): 268–281, https://doi.org/10.4236/iim.2015.75022.

MeSH terms

Substances

Grants and funding

LinkOut – more resources

BLACK HAWK: Best ashwagandha supplement for teens

Read the original publication:

Evaluating Blood-Brain Barrier Permeability, Cytotoxicity, and Activity of Potential Acetylcholinesterase Inhibitors: In Vitro and In Silico Study – PubMed